Q1 2026 earnings call recap: revenue up, traffic improving, comps down, promo-driven margin pressure, and Q2 guidance.

Q4 FY2026 earnings call recap: record free cash flow, AI Search rollout, FY2027 guidance, ad market softness & margin pressure—read now.

BGX pays out more than it earns, with a 7.7% yield unsupported by net investment income, risking further NAV declines. See ...

US clears 10 Chinese firms to buy Nvidia H200 AI chips, but deliveries remain stalled amid export curbs and Huang’s China ...

Franklin DynaTech Fund returned -10.90% in 1Q26, underperforming benchmarks due to consumer discretionary weakness. Read the ...

ConocoPhillips' oil-weighted production and disciplined capex position it to benefit from the ongoing supply shock. Read why ...

Blackstone ’s newly formed data center REIT, Blackstone Digital Infrastructure Trust, raised $1.75B in its U.S. IPO after ...

"We will introduce the 2.4 milligram pemvidutide dose in Phase III," Arbet-Engels said (Chief Medical Officer), describing PERFORMA as "an event-driven study" with "the interim analysis" at "52 weeks ...

AI chipmaker Cerebras Systems ( CBRS) raised $5.55B in its U.S. initial public offering, capitalizing on booming investor demand for artificial intelligence semiconductors.

Q1 2026 earnings call highlights: 49% revenue growth, 48% gross margin, $20M+ backlog, $40M LOI updates, outlook & risks—Read now.

Q1 commentary highlighted operational milestones in-flight ("planned in 2026 to supply 100%" of China lenses from Switzerland; ERP rollout with "limited business disruption"), whereas Q4 framed these ...

Q1 2026 earnings call recap: smart eyewear shipments, smartphone qualification reset, $130M+ Korea pipeline, and Q2 guidance—read now.